Claudia Garofalo - Garofalo Health Ex Director
| GHC Stock | EUR 4.87 0.02 0.41% |
Insider
Claudia Garofalo is Ex Director of Garofalo Health Care
| Age | 38 |
| Phone | 39 06 684891 |
| Web | https://www.garofalohealthcare.com |
Garofalo Health Management Efficiency
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0851 %, meaning that it generated $0.0851 on every $100 dollars invested by stockholders. Garofalo Health's management efficiency ratios could be used to measure how well Garofalo Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Alan Byers | SCOTT TECHNOLOGY | N/A | |
| John III | MACOM Technology Solutions | 53 | |
| John Morici | Align Technology | 56 | |
| Simon Beard | Align Technology | 56 | |
| Casey Jenkins | SCOTT TECHNOLOGY | N/A | |
| Joseph Hogan | Align Technology | 66 | |
| Fuk Poon | CITIC Telecom International | 57 | |
| Ambra Roth | MACOM Technology Solutions | 41 | |
| Yuet Cheung | CITIC Telecom International | 50 | |
| Kee Yuen | CITIC Telecom International | 74 | |
| Dawei Cai | CITIC Telecom International | 45 | |
| Mun Tso | CITIC Telecom International | 61 | |
| Jessen Wehrwein | MACOM Technology Solutions | N/A | |
| Hon Ip | CITIC Telecom International | 52 | |
| Vamsi Pudipeddi | Align Technology | 51 | |
| Emory Wright | Align Technology | 53 | |
| Julie Coletti | Align Technology | 54 | |
| Shirley Stacy | Align Technology | N/A | |
| Zhenjun Luan | CITIC Telecom International | 56 | |
| Stephen Ferranti | MACOM Technology Solutions | N/A | |
| Jennifer OlsonWilk | Align Technology | 45 | |
Management Performance
| Return On Equity | 0.0851 | |||
| Return On Asset | 0.0425 |
Garofalo Health Care Management Team
Elected by the shareholders, the Garofalo Health's board of directors comprises two types of representatives: Garofalo Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Garofalo. The board's role is to monitor Garofalo Health's management team and ensure that shareholders' interests are well served. Garofalo Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Garofalo Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Giuseppe Giannasio, Ex Director | ||
| Maria Garofalo, CEO Director | ||
| Claudia Garofalo, Ex Director |
Garofalo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Garofalo Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0851 | |||
| Return On Asset | 0.0425 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 467.88 M | |||
| Shares Outstanding | 89.09 M | |||
| Shares Owned By Insiders | 64.49 % | |||
| Shares Owned By Institutions | 21.72 % | |||
| Price To Earning | 40.71 X | |||
| Price To Book | 1.22 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Garofalo Stock
Garofalo Health financial ratios help investors to determine whether Garofalo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Garofalo with respect to the benefits of owning Garofalo Health security.